Nanoparticle Albumin Bound Paclitaxel in the Treatment of Human Cancer: Nanodelivery Reaches Prime-Time?
Journal of Drug Delivery · 02.05.2013 · 2013 · 1-10
DOI: 10.1155/2013/905091 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Drug Delivery, erschienen am 02.05.2013. Verfasst von Iole Cucinotto und 10 weiteren Autor:innen. Beteiligte Einrichtung: Medical Oncology Unit, Department of Experimental and Clinical Medicine, University "Magna Graecia" of Catanzaro and "Tommaso Campanella" Cancer Cent…. Die Arbeit wurde bisher 82-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
Nanoparticle albumin bound paclitaxel (nab-paclitaxel) represents the first nanotechnology-based drug in cancer treatment. We discuss the development of this innovative compound and report the recent changing-practice results in breast and pancreatic cancer. A ground-breaking finding is the demonstration that nab-paclitaxel can not only enhance the activity and reduce the toxicity of chromophore-diluted compound, but also exert activity in diseases considered refractory to taxane-based treatment. This is the first clinical demonstration of major activity of nanotechnologically modified drugs in the treatment of human neoplasms.
Autor:innen und Institutionen
- Medical Oncology Unit, Department of Experimental and Clinical Medicine, University "Magna Graecia" of Catanzaro and "Tommaso Campanella" Cancer Center, Campus Salvatore Venuta, Viale Europa, 88100 Catanzaro, Italy.
Zitieren
APA
Cucinotto, I., Fiorillo, L., Gualtieri, S., Arbitrio, M., Ciliberto, D., Staropoli, N., Grimaldi, A., Luce, A., Tassone, P., Caraglia, M., & Tagliaferri, P. (2013). Nanoparticle Albumin Bound Paclitaxel in the Treatment of Human Cancer: Nanodelivery Reaches Prime-Time?. Journal of Drug Delivery, 2013, 1-10. https://doi.org/10.1155/2013/905091
Vancouver
Cucinotto I, Fiorillo L, Gualtieri S, Arbitrio M, Ciliberto D, Staropoli N, et al. Nanoparticle Albumin Bound Paclitaxel in the Treatment of Human Cancer: Nanodelivery Reaches Prime-Time?. Journal of Drug Delivery. 2013;2013:1-10. doi:10.1155/2013/905091
BibTeX
@article{Cucinotto2013,
author = {Cucinotto, Iole and Fiorillo, Lucia and Gualtieri, Simona and Arbitrio, Mariamena and Ciliberto, Domenico and Staropoli, Nicoletta and Grimaldi, Anna and Luce, Amalia and Tassone, Pierfrancesco and Caraglia, Michele and Tagliaferri, Pierosandro},
title = {Nanoparticle Albumin Bound Paclitaxel in the Treatment of Human Cancer: Nanodelivery Reaches Prime-Time?},
journal = {Journal of Drug Delivery},
year = {2013},
volume = {2013},
pages = {1--10},
doi = {10.1155/2013/905091}
}
EUVIMED